Addictive drugs cause persistent restructuring of several neuronal cell types in the limbic regions of brain thought to be responsible for long-term behavioral plasticity driving addiction. Although these structural changes are well documented in nucleus accumbens medium spiny neurons, little is known regarding the underlying molecular mechanisms. Additionally, it remains unclear whether structural plasticity and its synaptic concomitants drive addictive behaviors or whether they reflect homeostatic compensations to the drug not related to addiction per se. Here, we discuss recent paradoxical data, which either support or oppose the hypothesis that drug-induced changes in dendritic spines drive addictive behavior. We define areas where future investigation can provide a more detailed picture of drug-induced synaptic reorganization, including ultrastructural, electrophysiological and behavioral studies. Introduction Drug addiction is marked by long-lasting changes in behavior, such as craving and relapse. Correlated with these stable behavioral abnormalities is the persistent restructuring of many neuronal cell types in limbic regions of the brain. Two general types of structural plasticity have been observed: changes in the size of cell bodies [1] and changes in dendritic arborizations or spine morphology [2]. With regard to the latter, depending upon the class of addictive substance, nature of the drug administration paradigm (e.g. experimenter versus self-administered), and neuronal cell type examined, drugs of abuse can alter the complexity of dendritic branching, as well as the number and size of dendritic spines on neurons in several brain regions (Table 1 ). Correlative evidence suggests that certain morphological changes are important mediators of addictive behaviors. For example, morphine and cocaine alter the density of dendritic spines on medium spiny neurons (MSNs) in nucleus accumbens (NAc), a key brain reward region, to a greater extent in animals self-administering the drug, compared with animals given the drug by the investigator, suggesting that volition can be important for key aspects of plasticity (reviewed in Ref. [3] ). Additionally,
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[3]). Additionally, cocaine-induced changes in NAc dendritic structure are tightly correlated with the induction of behavioral sensitization [4]: doses and drug administration paradigms that induce sensitization reliably increase dendritic spines and branching. Despite this evidence, however, the behavioral Review Glossary Actin-related proteins: the actin cytoskeleton is regulated by a large number of proteins; however, the detailed role of each in ultimately growing or retracting a spine, or altering a spine's size and shape, remain incompletely understood. Examples include actin-related proteins (ARPs), Wiskott-Aldrich syndrome proteins (WASPs), WASP-family verprolin homologs (WAVEs) and cofilin, among many others. Addiction-related behavior: this is most often studied by use of drug selfadministration paradigms, including acquisition and maintenance of selfadministration, withdrawal and extinction, as well as reinstatement (relapse). Brain reward regions: these include midbrain dopaminergic neurons in the ventral tegmental area, and the limbic regions to which these neurons project, including the nucleus accumbens (ventral striatum), amygdala, hippocampus and several regions of prefrontal cortex (e.g. medial, orbitofrontal, etc.). Dopamine receptor: two major types of dopamine receptors are expressed in nucleus accumbens, containing either dopamine receptor D1 or D2 (Drd1 or Drd2) Drd1 or Drd2 receptors, which differ in their post-receptor signaling mechanisms. Drd1 receptors are Gs-coupled and stimulate adenylyl cyclase, whereas Drd2 receptors are Gi/o-coupled and inhibit adenylyl cyclase, activate inwardly rectifying K + channels and inhibit voltage-gated Ca 2+ channels. Both receptors can also regulate extracellular signal regulated kinase (ERK) cascades. Glutamate receptors: the major ionotropic glutamate receptors in brain are named for specific agonists, a-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) and N-methyl-D-aspartate (NMDA). Opiate treatment paradigms: this includes experimenter-or self-administered morphine, heroin or other opiate drugs of abuse at a given dose and frequency for a given duration of time. Animals are then analyzed at varying times after the last drug dose. Protein kinases: several protein kinases, enzymes that phosphorylate other proteins to regulate their function, have been implicated in the control of dendritic spine formation, including Ca 2+ /calmodulin-dependent protein kinase II (CaMKII), cyclin-dependent kinase 5 (Cdk5), p21-activated kinase (PAK1) and lim domain kinase (LIMK), among many others. RhoGTPases: these small G proteins play a central role in regulation of the actin cytoskeleton, thought to be integral in the growth and retraction of dendritic spines. They are activated by guanine nucleotide exchange factors (GEFs) and inhibited by GTPase-activating proteins (GAPs). Stimulant treatment regimens: this includes experimenter-or self-administered cocaine, amphetamine or nicotine at a given dose and frequency for a given duration of time. Animals are then analyzed at varying times after the last drug dose. Transcription factors: these are proteins that bind to specific DNA sequences (called response elements) within responsive genes and thereby increase or decrease the rate at which those genes are transcribed. Examples of transcription factors that regulate dendritic spines are: DFosB (a Fos family protein), cyclic AMP response element binding protein (CREB), nuclear factor kB (NFkB), and myocyte-enhancing factor 2 (MEF2). Corresponding author: Russo, S.J. (scott.russo@mssm.edu). 
